These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 39173527

  • 1. Microbiome-driven IBS metabotypes influence response to the low FODMAP diet: insights from the faecal volatome.
    Conley TE, Slater R, Moss S, Bulmer DC, Negro JR, Ijaz UZ, Pritchard DM, Parkes M, Probert C.
    EBioMedicine; 2024 Sep; 107():105282. PubMed ID: 39173527
    [Abstract] [Full Text] [Related]

  • 2. Fecal Fermentation in Irritable Bowel Syndrome: Influence of Dietary Restriction of Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols.
    Valeur J, Røseth AG, Knudsen T, Malmstrøm GH, Fiennes JT, Midtvedt T, Berstad A.
    Digestion; 2016 Sep; 94(1):50-6. PubMed ID: 27487397
    [Abstract] [Full Text] [Related]

  • 3. Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial.
    Yan R, Murphy M, Genoni A, Marlow E, Dunican IC, Lo J, Andrew L, Devine A, Christophersen CT.
    BMJ Open Gastroenterol; 2020 Aug; 7(1):. PubMed ID: 32816830
    [Abstract] [Full Text] [Related]

  • 4. Two microbiota subtypes identified in irritable bowel syndrome with distinct responses to the low FODMAP diet.
    Vervier K, Moss S, Kumar N, Adoum A, Barne M, Browne H, Kaser A, Kiely CJ, Neville BA, Powell N, Raine T, Stares MD, Zhu A, De La Revilla Negro J, Lawley TD, Parkes M.
    Gut; 2022 Sep; 71(9):1821-1830. PubMed ID: 34810234
    [Abstract] [Full Text] [Related]

  • 5. FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial.
    McIntosh K, Reed DE, Schneider T, Dang F, Keshteli AH, De Palma G, Madsen K, Bercik P, Vanner S.
    Gut; 2017 Jul; 66(7):1241-1251. PubMed ID: 26976734
    [Abstract] [Full Text] [Related]

  • 6. Exploring Gut Microbiota Composition as an Indicator of Clinical Response to Dietary FODMAP Restriction in Patients with Irritable Bowel Syndrome.
    Valeur J, Småstuen MC, Knudsen T, Lied GA, Røseth AG.
    Dig Dis Sci; 2018 Feb; 63(2):429-436. PubMed ID: 29302878
    [Abstract] [Full Text] [Related]

  • 7. Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs.
    Bennet SMP, Böhn L, Störsrud S, Liljebo T, Collin L, Lindfors P, Törnblom H, Öhman L, Simrén M.
    Gut; 2018 May; 67(5):872-881. PubMed ID: 28416515
    [Abstract] [Full Text] [Related]

  • 8. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.
    Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG.
    Gastroenterology; 2014 Jan; 146(1):67-75.e5. PubMed ID: 24076059
    [Abstract] [Full Text] [Related]

  • 9. Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet.
    Staudacher HM, Whelan K.
    Proc Nutr Soc; 2016 Aug; 75(3):306-18. PubMed ID: 26908093
    [Abstract] [Full Text] [Related]

  • 10. The gut microbiome as a predictor of low fermentable oligosaccharides disaccharides monosaccharides and polyols diet efficacy in functional bowel disorders.
    Chumpitazi BP.
    Curr Opin Gastroenterol; 2020 Mar; 36(2):147-154. PubMed ID: 31850930
    [Abstract] [Full Text] [Related]

  • 11. Effects of Low-FODMAPS Diet on Irritable Bowel Syndrome Symptoms and Gut Microbiome.
    Su H, Li YT, Heitkemper MM, Zia J.
    Gastroenterol Nurs; 2019 Mar; 42(2):150-158. PubMed ID: 30946302
    [Abstract] [Full Text] [Related]

  • 12. Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet: A meta-analysis of clinical studies.
    Varjú P, Farkas N, Hegyi P, Garami A, Szabó I, Illés A, Solymár M, Vincze Á, Balaskó M, Pár G, Bajor J, Szűcs Á, Huszár O, Pécsi D, Czimmer J.
    PLoS One; 2017 Mar; 12(8):e0182942. PubMed ID: 28806407
    [Abstract] [Full Text] [Related]

  • 13. A low FODMAP diet plus traditional dietary advice versus a low-carbohydrate diet versus pharmacological treatment in irritable bowel syndrome (CARIBS): a single-centre, single-blind, randomised controlled trial.
    Nybacka S, Törnblom H, Josefsson A, Hreinsson JP, Böhn L, Frändemark Å, Weznaver C, Störsrud S, Simrén M.
    Lancet Gastroenterol Hepatol; 2024 Jun; 9(6):507-520. PubMed ID: 38643782
    [Abstract] [Full Text] [Related]

  • 14. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome.
    Chumpitazi BP, Cope JL, Hollister EB, Tsai CM, McMeans AR, Luna RA, Versalovic J, Shulman RJ.
    Aliment Pharmacol Ther; 2015 Aug; 42(4):418-27. PubMed ID: 26104013
    [Abstract] [Full Text] [Related]

  • 15. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome.
    Staudacher HM, Whelan K, Irving PM, Lomer MC.
    J Hum Nutr Diet; 2011 Oct; 24(5):487-95. PubMed ID: 21615553
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The impact of dietary fermentable carbohydrates on a postinflammatory model of irritable bowel syndrome.
    Tuck CJ, Caminero A, Jiménez Vargas NN, Soltys CL, Jaramillo Polanco JO, Lopez Lopez CD, Constante M, Lourenssen SR, Verdu EF, Muir JG, Lomax AE, Reed DE, Vanner SJ.
    Neurogastroenterol Motil; 2019 Oct; 31(10):e13675. PubMed ID: 31290223
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.